PMC:7417114 / 49240-49401 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T251","span":{"begin":89,"end":95},"obj":"Body_part"}],"attributes":[{"id":"A251","pred":"fma_id","subj":"T251","obj":"http://purl.org/sig/ont/fma/fma9601"}],"text":"1,250 mg orally once daily continuously in combination with capecitabine (for metastatic breast cancer); 1,500 mg orally once daily in combination with letrozole"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T71","span":{"begin":89,"end":95},"obj":"Body_part"}],"attributes":[{"id":"A71","pred":"uberon_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"1,250 mg orally once daily continuously in combination with capecitabine (for metastatic breast cancer); 1,500 mg orally once daily in combination with letrozole"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T474","span":{"begin":89,"end":102},"obj":"Disease"},{"id":"T475","span":{"begin":96,"end":102},"obj":"Disease"}],"attributes":[{"id":"A474","pred":"mondo_id","subj":"T474","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A475","pred":"mondo_id","subj":"T475","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"1,250 mg orally once daily continuously in combination with capecitabine (for metastatic breast cancer); 1,500 mg orally once daily in combination with letrozole"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T568","span":{"begin":89,"end":95},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"1,250 mg orally once daily continuously in combination with capecitabine (for metastatic breast cancer); 1,500 mg orally once daily in combination with letrozole"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T420","span":{"begin":60,"end":72},"obj":"Chemical"},{"id":"T421","span":{"begin":152,"end":161},"obj":"Chemical"}],"attributes":[{"id":"A420","pred":"chebi_id","subj":"T420","obj":"http://purl.obolibrary.org/obo/CHEBI_31348"},{"id":"A421","pred":"chebi_id","subj":"T421","obj":"http://purl.obolibrary.org/obo/CHEBI_6413"}],"text":"1,250 mg orally once daily continuously in combination with capecitabine (for metastatic breast cancer); 1,500 mg orally once daily in combination with letrozole"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T133","span":{"begin":89,"end":102},"obj":"Phenotype"}],"attributes":[{"id":"A133","pred":"hp_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"1,250 mg orally once daily continuously in combination with capecitabine (for metastatic breast cancer); 1,500 mg orally once daily in combination with letrozole"}